data_1g5m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1g5m _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.845 0.355 . . . . 10.34 111.171 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.43 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 6.1900000000000004 111.102 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.65 -154.18 1.93 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 4.5499999999999998 112.419 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.88 126.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.8 0.334 . . . . 8.3100000000000005 110.923 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -177.52 58.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 3.3900000000000001 110.898 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.51 154.01 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.758 . . . . 2.77 112.42 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 195' ' ' TRP . 4.5 m-85 -112.63 22.52 14.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.55 0.214 . . . . 2.1699999999999999 111.467 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.13 62.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 2.2000000000000002 110.833 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -49.48 -41.12 39.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 2.8399999999999999 110.923 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -70.38 -32.15 69.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 2.9199999999999999 110.838 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -79.51 -30.09 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 2.1200000000000001 110.894 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.46 ' CD1' ' CZ2' ' A' ' 195' ' ' TRP . 5.8 mt -67.32 -44.83 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 1.46 111.154 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.44 -44.66 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.1100000000000001 111.06 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.2 -39.18 92.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 1.3100000000000001 110.87 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -60.67 -48.0 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 2.5499999999999998 110.838 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 151' ' ' PHE . 66.1 t80 -54.95 -52.87 61.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 1.3500000000000001 110.91 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.416 HG23 ' CZ3' ' A' ' 30' ' ' TRP . 11.0 mt -63.17 -38.75 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 1.46 111.111 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.87 -37.81 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 2.3999999999999999 110.808 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -55.49 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 2.0299999999999998 110.827 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -51.93 -31.02 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 2.46 110.869 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.5 tp -84.08 -40.81 17.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 1.8500000000000001 110.747 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -49.18 -27.14 3.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 1.5 111.139 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.72 10.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.387 -0.37 . . . . 3.2999999999999998 110.75 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -93.05 -35.68 13.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.368 -0.378 . . . . 4.1500000000000004 111.055 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.77 15.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.679 -0.772 . . . . 1.8600000000000001 112.849 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.425 ' CE2' HG22 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -47.21 106.11 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.877 0.37 . . . . 1.8799999999999999 110.959 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.87 110.71 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 2.4500000000000002 110.856 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.427 ' CE2' HG23 ' A' ' 170' ' ' VAL . 21.5 t90 -96.38 -66.27 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 1.1699999999999999 111.177 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.6 24.51 2.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 2.3799999999999999 111.24 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.422 ' HA ' ' CZ2' ' A' ' 30' ' ' TRP . . . 75.77 -58.7 0.54 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.555 -0.293 . . . . 1.55 111.598 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.61 68.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.638 -0.792 . . . . 1.8700000000000001 112.597 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 48.02 30.97 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 3.9100000000000001 110.958 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.14 31.69 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 4.4699999999999998 110.906 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 178.95 107.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 5.3600000000000003 111.117 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.36 -57.94 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 6.7300000000000004 110.875 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -143.32 179.68 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 8.2200000000000006 110.912 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.3 51.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 7.0999999999999996 110.859 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -28.75 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 10.26 111.126 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -39.92 19.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.356 -0.383 . . . . 6.4800000000000004 110.977 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.56 127.17 29.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 7.4299999999999997 110.784 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.2 141.05 22.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 5.0599999999999996 111.085 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -59.75 82.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.422 2.081 . . . . 6.3099999999999996 112.288 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -165.98 177.63 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.6799999999999997 111.017 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.26 -68.56 0.42 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.818 -0.705 . . . . 3.8799999999999999 112.442 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.2 p 53.96 30.66 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 4.1399999999999997 110.993 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 4.6 pt-20 -129.82 4.47 4.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.28 -0.418 . . . . 3.3300000000000001 111.851 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.25 38.1 0.95 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.842 0.353 . . . . 1.74 110.781 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -100.22 -25.72 14.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 2.8399999999999999 111.28 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.81 -24.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.504 -0.316 . . . . 1.49 111.672 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.0 p -62.78 -41.07 91.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.97 0.414 . . . . 1.3200000000000001 110.626 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.416 ' CE1' HG12 ' A' ' 14' ' ' ILE . 66.7 m-70 -74.03 -53.96 8.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.549 . . . . 1.3100000000000001 110.584 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.6 mt -48.34 -44.27 34.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 2.5899999999999999 110.611 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.58 -60.92 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 1.1799999999999999 110.847 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' A' ' 198' ' ' PHE . 9.0 tt -46.45 -42.77 15.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 1.6499999999999999 110.998 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -30.13 68.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 3.25 110.91 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.91 -50.56 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 2.2000000000000002 110.77 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -48.13 -41.15 25.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 1.1499999999999999 111.15 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -53.59 -49.14 58.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.59999999999999998 112.522 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.51 -46.84 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 2.0600000000000001 110.864 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.81 -30.29 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 1.8799999999999999 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -92.34 -59.26 2.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 2.25 111.073 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -47.29 -36.36 9.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 1.3999999999999999 110.988 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -75.87 -29.05 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 3.5699999999999998 110.989 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -59.7 -46.93 87.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 3.5899999999999999 110.821 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -78.95 -70.05 0.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 1.96 110.855 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 65.56 13.78 9.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 3.5499999999999998 111.748 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.63 -43.69 1.42 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.517 -0.849 . . . . 1.1499999999999999 112.454 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.07 -170.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.657 0.265 . . . . 2.2599999999999998 110.826 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 68.54 -84.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 2.0 111.774 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.04 -68.84 0.16 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.783 0.325 . . . . 1.3899999999999999 111.28 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.31 -30.18 69.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 3.21 110.715 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 57.0 ttp -56.98 -22.21 36.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.8700000000000001 111.16 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -12.56 47.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.038 0.384 . . . . 2.3999999999999999 112.038 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.6 t -66.6 -30.7 71.05 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.74 0.305 . . . . 1.96 110.715 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -61.12 2.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 3.0899999999999999 110.757 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 tt -50.37 147.36 4.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 2.3500000000000001 110.812 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -67.38 -123.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.244 -0.434 . . . . 3.3100000000000001 110.424 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 179.06 98.07 0.02 OUTLIER 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.659 0.663 . . . . 2.4900000000000002 110.475 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 167.37 164.5 0.13 Allowed Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.188 -0.46 . . . . 3.3100000000000001 110.497 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.81 -25.52 45.74 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.518 2.145 . . . . 2.6400000000000001 112.07 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 70.0 t80 -95.17 21.83 7.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.248 -0.433 . . . . 4.8099999999999996 111.317 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.17 -56.22 1.26 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.637 0.256 . . . . 2.71 111.075 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -45.25 -39.25 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 1.77 111.612 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 2.8999999999999999 111.179 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.18 -59.14 10.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.65000000000000002 112.789 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -42.76 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 3.0899999999999999 111.234 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.52 -44.88 36.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 2.2999999999999998 110.948 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.22 97.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 1.26 111.162 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 m -64.08 -58.71 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 1.28 111.069 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.01 -54.31 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.1899999999999999 111.317 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.96 -41.31 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 111.389 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.87 -45.0 59.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 2.1400000000000001 110.835 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.67 -34.05 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 2.5600000000000001 111.321 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 mt -50.89 -55.07 18.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 1.71 110.807 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CD1' HG13 ' A' ' 142' ' ' VAL . 45.9 m-85 -103.56 7.76 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 2.2400000000000002 112.047 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -44.29 -39.51 4.58 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.658 0.266 . . . . 4.8399999999999999 111.392 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.95 76.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.459 -0.337 . . . . 3.2000000000000002 110.909 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.79 147.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 1.5600000000000001 112.475 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 138' ' ' PHE . 2.5 t -99.9 143.01 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 1.3899999999999999 111.445 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.422 ' HA ' ' CZ2' ' A' ' 188' ' ' TRP . 7.7 m-20 -150.65 161.94 41.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.641 . . . . 2.1800000000000002 110.501 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.498 ' CZ3' ' CD2' ' A' ' 198' ' ' PHE . 12.6 m95 -49.96 -62.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.39000000000000001 110.653 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.24 -40.19 21.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.37 112.101 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -36.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 2.73 110.316 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 2.4 mt -64.43 -55.56 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.106 -0.497 . . . . 1.3400000000000001 110.03 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -48.3 -36.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.773 -0.648 . . . . 1.1200000000000001 110.376 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.5 -39.17 88.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.004 -0.544 . . . . 1.1100000000000001 110.662 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.17 -34.22 74.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 2.3999999999999999 110.829 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 24.5 m-85 -67.7 -61.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 2.1699999999999999 110.615 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -40.09 18.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 2.25 110.923 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -54.99 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 1.8999999999999999 110.772 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.71 -34.11 60.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.638 -0.792 . . . . 0.37 112.374 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.35 -34.15 87.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 0.39000000000000001 112.328 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.83 -42.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 1.3100000000000001 110.999 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 3.5 ttp -64.12 -41.35 97.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 1.48 110.841 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -62.14 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 1.3999999999999999 110.818 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.2 t -48.74 -34.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 1.3700000000000001 110.841 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -61.26 -39.76 91.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 2.3300000000000001 110.596 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -62.26 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.6499999999999999 110.774 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.425 HG22 ' CE2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -53.23 -25.22 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 1.53 111.209 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -72.6 -41.87 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.4 -0.364 . . . . 1.73 110.572 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -93.39 23.53 4.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 4.5599999999999996 111.785 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 69.7 32.92 3.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.75 0.31 . . . . 2.5699999999999998 111.281 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.75 46.43 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 1.73 110.87 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -51.14 -53.64 46.51 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.6399999999999999 111.217 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 167' ' ' SER . 76.3 Cg_exo -47.83 -28.49 9.92 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.657 2.238 . . . . 0.82999999999999996 112.699 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.93 -30.3 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 2.2599999999999998 111.129 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.427 HG23 ' CE2' ' A' ' 30' ' ' TRP . 2.6 m -60.66 -28.03 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.421 -0.354 . . . . 1.71 111.195 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.82 -50.38 50.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 1.75 110.853 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.413 ' HB3' ' CZ2' ' A' ' 176' ' ' TRP . 1.4 m-20 -59.91 -32.9 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.8 110.802 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 1.2 mt -63.73 -61.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 1.2 111.001 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -49.2 -34.25 14.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 1.1499999999999999 111.01 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.419 HD23 ' CD1' ' A' ' 176' ' ' TRP . 0.5 OUTLIER -67.43 -61.61 1.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 1.52 110.688 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.419 ' CD1' HD23 ' A' ' 175' ' ' LEU . 22.1 m0 -45.66 -51.01 12.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.974 -0.557 . . . . 0.40999999999999998 110.807 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.6 mtp -53.03 -52.64 57.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 1.5700000000000001 110.797 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.1 m -50.01 -44.67 51.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.98999999999999999 110.823 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -53.84 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 2.25 110.859 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -47.38 -38.98 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 1.21 111.065 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.78 -49.82 61.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 1.4299999999999999 111.616 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.51 -27.07 24.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.742 0.306 . . . . 2.1099999999999999 111.704 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.4 ' HB3' ' CD2' ' A' ' 184' ' ' HIS . 3.9 ttt180 -65.89 -73.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.445 0.535 . . . . 2.4700000000000002 112.445 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.4 ' CD2' ' HB3' ' A' ' 183' ' ' ARG . 4.1 m-70 -93.86 -38.56 11.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.722 0.638 . . . . 0.48999999999999999 112.722 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 5.4 mt -64.91 -36.53 84.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.153 0.427 . . . . 1.24 112.153 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -48.09 -56.96 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.735 0.302 . . . . 2.1600000000000001 111.313 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.6 m -48.25 -55.61 10.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.375 . . . . 1.8200000000000001 111.249 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.449 ' CZ2' ' ND2' ' A' ' 192' ' ' ASN . 44.0 t90 -63.63 -40.26 96.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.96999999999999997 111.628 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.3 mt -46.72 -58.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.466 -0.334 . . . . 1.26 111.323 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.41 -29.64 69.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.386 . . . . 2.6699999999999999 111.089 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.63 -45.64 85.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 1.96 111.184 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.449 ' ND2' ' CZ2' ' A' ' 188' ' ' TRP . 1.7 t-20 -73.27 -17.59 61.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 1.8600000000000001 111.771 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.94 4.69 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.323 -0.941 . . . . 1.1399999999999999 113.537 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.68 178.02 45.51 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.539 -0.839 . . . . 0.72999999999999998 113.095 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TRP . . . . . 0.46 ' CZ2' ' CD1' ' A' ' 14' ' ' ILE . 50.7 m95 -47.48 -45.47 26.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.729 0.3 . . . . 0.54000000000000004 110.505 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -48.72 -32.76 8.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.252 -0.431 . . . . 2.1600000000000001 110.419 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.75 -39.5 64.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.93000000000000005 110.094 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.498 ' CD2' ' CZ3' ' A' ' 144' ' ' TRP . 0.2 OUTLIER -63.11 -62.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 2.0600000000000001 110.278 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -46.53 -49.97 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.758 -0.655 . . . . 1.45 111.605 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.72 -37.34 87.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 2.23 111.349 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.25 -58.35 7.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.303 0.483 . . . . 1.55 112.303 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -100.37 9.69 42.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.65 0.611 . . . . 1.8 112.65 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -78.23 149.18 33.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.324 -0.941 . . . . 0.94999999999999996 112.633 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 -158.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.612 2.208 . . . . 2.1099999999999999 112.24 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.3 m -118.26 79.1 1.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 4.0099999999999998 110.864 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' MET . . . . . . . . . . . . . 1.9 mtm 69.21 54.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 7.1500000000000004 110.889 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.26 -0.876 . . . . 8.0399999999999991 110.943 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.845 0.355 . . . . 9.58 111.171 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.43 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 5.87 111.102 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.65 -154.18 1.93 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 4.36 112.419 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.88 126.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.8 0.334 . . . . 7.64 110.923 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 7' ' ' THR . 8.8 t -177.52 58.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 3.07 110.898 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.51 154.01 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.758 . . . . 2.3 112.42 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 195' ' ' TRP . 4.5 m-85 -112.63 22.52 14.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.55 0.214 . . . . 1.74 111.467 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.13 62.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 2.2 110.833 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -49.48 -41.12 39.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 2.39 110.923 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -70.38 -32.15 69.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 2.27 110.838 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -79.51 -30.09 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 2.12 110.894 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.89 HD13 ' CZ2' ' A' ' 195' ' ' TRP . 5.8 mt -67.32 -44.83 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.75 111.154 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.703 HG23 HD12 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -71.44 -44.66 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.34 111.06 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.2 -39.18 92.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.85 110.87 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.58 ' HE2' ' CD2' ' A' ' 94' ' ' HIS . 16.6 mtpp -60.67 -48.0 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 2.06 110.838 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 151' ' ' PHE . 66.1 t80 -54.95 -52.87 61.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.88 110.91 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.0 mt -63.17 -38.75 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.7 111.111 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.87 -37.81 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 1.81 110.808 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -55.49 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 1.23 110.827 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -51.93 -31.02 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 1.94 110.869 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.499 HD11 ' HD2' ' A' ' 28' ' ' TYR . 11.5 tp -84.08 -40.81 17.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 1.23 110.747 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -49.18 -27.14 3.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 1.3 111.139 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.72 10.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.387 -0.37 . . . . 2.76 110.75 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.424 ' CD ' HG22 ' A' ' 159' ' ' VAL . 14.2 mtt85 -93.05 -35.68 13.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.368 -0.378 . . . . 3.49 111.055 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.77 15.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.679 -0.772 . . . . 1.86 112.849 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.78 ' CD2' HG21 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -47.21 106.11 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.877 0.37 . . . . 1.17 110.959 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.87 110.71 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 2.45 110.856 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.441 ' CE2' ' HA ' ' A' ' 32' ' ' ALA . 21.5 t90 -96.38 -66.27 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 1.17 111.177 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER 72.6 24.51 2.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 2.38 111.24 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 31' ' ' ASP . . . 75.77 -58.7 0.54 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.555 -0.293 . . . . 1.28 111.598 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.61 68.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.638 -0.792 . . . . 1.87 112.597 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 48.02 30.97 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 3.91 110.958 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.51 ' C ' HG12 ' A' ' 36' ' ' VAL . 3.7 t70 -106.14 31.69 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 4.47 110.906 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG12 ' C ' ' A' ' 35' ' ' ASP . 0.2 OUTLIER 178.95 107.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 4.85 111.117 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.36 -57.94 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 6.73 110.875 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -143.32 179.68 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 8.22 110.912 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.3 51.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 6.7 110.859 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -28.75 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 9.63 111.126 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -39.92 19.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.356 -0.383 . . . . 6.21 110.977 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.56 127.17 29.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 7.43 110.784 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . . . -98.2 141.05 22.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 4.54 111.085 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 37.2 Cg_exo -59.75 82.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.422 2.081 . . . . 5.78 112.288 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -165.98 177.63 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.68 111.017 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.26 -68.56 0.42 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.818 -0.705 . . . . 3.41 112.442 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.2 p 53.96 30.66 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 3.87 110.993 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 4.6 pt-20 -129.82 4.47 4.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.28 -0.418 . . . . 3.33 111.851 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.591 ' HA ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -147.25 38.1 0.95 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.842 0.353 . . . . 1.52 110.781 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -100.22 -25.72 14.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 2.84 111.28 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -114.81 -24.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.504 -0.316 . . . . 0.95 111.672 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 49' ' ' SER . 11.0 p -62.78 -41.07 91.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.97 0.414 . . . . 0.67 110.626 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.58 ' CD2' ' HE2' ' A' ' 17' ' ' LYS . 74.9 m80 -74.03 -53.96 8.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.549 . . . . 1.09 110.584 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.6 mt -48.34 -44.27 34.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 2.05 110.611 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 202' ' ' TYR . . . -68.58 -60.92 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 0.61 110.847 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.826 HD12 ' CE2' ' A' ' 198' ' ' PHE . 9.0 tt -46.45 -42.77 15.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 1.1 110.998 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -30.13 68.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 2.83 110.91 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.91 -50.56 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 1.72 110.77 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 148' ' ' VAL . . . -48.13 -41.15 25.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.5 111.15 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA2' HG13 ' A' ' 148' ' ' VAL . . . -53.59 -49.14 58.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.55 112.522 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.51 -46.84 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 2.06 110.864 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.81 -30.29 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 1.88 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -92.34 -59.26 2.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 1.48 111.073 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -47.29 -36.36 9.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 1.07 110.988 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -75.87 -29.05 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 3.08 110.989 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -59.7 -46.93 87.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 3.04 110.821 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -78.95 -70.05 0.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 1.35 110.855 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 65.56 13.78 9.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 2.98 111.748 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.63 -43.69 1.42 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.517 -0.849 . . . . 1.05 112.454 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.07 -170.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.657 0.265 . . . . 2.26 110.826 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.768 ' CZ ' ' HB1' ' A' ' 149' ' ' ALA . 5.0 m-85 68.54 -84.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 1.57 111.774 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.04 -68.84 0.16 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.783 0.325 . . . . 0.92 111.28 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.31 -30.18 69.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 3.21 110.715 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 57.0 ttp -56.98 -22.21 36.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.45 111.16 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -12.56 47.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.038 0.384 . . . . 2.14 112.038 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.6 t -66.6 -30.7 71.05 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.74 0.305 . . . . 1.64 110.715 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -61.12 2.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 2.52 110.757 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 129' ' ' ARG . 8.8 tt -50.37 147.36 4.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 1.84 110.812 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.654 ' HB3' HG21 ' A' ' 125' ' ' THR . 11.5 t-160 -67.38 -123.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.244 -0.434 . . . . 2.68 110.424 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.631 ' O ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER 179.06 98.07 0.02 OUTLIER 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.659 0.663 . . . . 1.93 110.475 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 169' ' ' LEU . 0.2 OUTLIER 167.37 164.5 0.13 Allowed Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.188 -0.46 . . . . 2.79 110.497 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HA ' HD21 ' A' ' 169' ' ' LEU . 39.1 Cg_endo -66.81 -25.52 45.74 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.518 2.145 . . . . 2.19 112.07 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 70.0 t80 -95.17 21.83 7.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.248 -0.433 . . . . 3.98 111.317 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 120' ' ' HIS . 0.6 OUTLIER -128.17 -56.22 1.26 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.637 0.256 . . . . 2.26 111.075 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.422 ' HA ' HD11 ' A' ' 119' ' ' LEU . . . -45.25 -39.25 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 1.77 111.612 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 2.27 111.179 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.18 -59.14 10.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.65 112.789 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.686 ' HB3' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -47.16 -42.76 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 2.65 111.234 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.52 -44.88 36.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 1.44 110.948 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.22 97.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.58 111.162 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 m -64.08 -58.71 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.73 111.069 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.01 -54.31 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.47 111.317 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.96 -41.31 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.49 111.389 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.87 -45.0 59.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 2.14 110.835 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.67 -34.05 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 2.56 111.321 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 mt -50.89 -55.07 18.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 1.08 110.807 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.862 ' CD1' HG13 ' A' ' 142' ' ' VAL . 45.9 m-85 -103.56 7.76 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 1.36 112.047 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -44.29 -39.51 4.58 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.658 0.266 . . . . 4.36 111.392 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.95 76.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.459 -0.337 . . . . 3.2 110.909 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.79 147.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 0.9 112.475 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.862 HG13 ' CD1' ' A' ' 138' ' ' PHE . 2.5 t -99.9 143.01 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 1.24 111.445 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.431 ' HA ' ' CZ2' ' A' ' 188' ' ' TRP . 7.7 m-20 -150.65 161.94 41.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.641 . . . . 2.05 110.501 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.747 ' CD1' HD13 ' A' ' 201' ' ' LEU . 12.6 m95 -49.96 -62.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.36 110.653 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.24 -40.19 21.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.34 112.101 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -36.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 2.22 110.316 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 143' ' ' ASN . 2.4 mt -64.43 -55.56 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.106 -0.497 . . . . 0.7 110.03 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.609 HG23 ' HZ ' ' A' ' 198' ' ' PHE . 0.9 OUTLIER -48.3 -36.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.773 -0.648 . . . . 0.35 110.376 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.768 ' HB1' ' CZ ' ' A' ' 112' ' ' PHE . . . -66.5 -39.17 88.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.004 -0.544 . . . . 0.32 110.662 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.17 -34.22 74.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 1.47 110.829 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 24.5 m-85 -67.7 -61.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 1.28 110.615 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -40.09 18.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 2.25 110.923 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -54.99 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 1.15 110.772 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.71 -34.11 60.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.638 -0.792 . . . . 0.37 112.374 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.35 -34.15 87.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 0.39 112.328 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.83 -42.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.59 110.999 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 3.5 ttp -64.12 -41.35 97.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 1.15 110.841 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.427 ' HA ' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -60.99 -62.14 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 1.19 110.818 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.424 HG22 ' CD ' ' A' ' 26' ' ' ARG . 1.2 t -48.74 -34.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.77 110.841 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -61.26 -39.76 91.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 2.33 110.596 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -62.26 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.17 110.774 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.78 HG21 ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -53.23 -25.22 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.91 111.209 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -72.6 -41.87 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.4 -0.364 . . . . 1.65 110.572 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -93.39 23.53 4.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 4.01 111.785 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 69.7 32.92 3.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.75 0.31 . . . . 2.57 111.281 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.75 46.43 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 1.06 110.87 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -51.14 -53.64 46.51 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.41 111.217 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 167' ' ' SER . 76.3 Cg_exo -47.83 -28.49 9.92 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.657 2.238 . . . . 0.63 112.699 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 122' ' ' THR . 0.5 OUTLIER -64.93 -30.3 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 1.64 111.129 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 167' ' ' SER . 2.6 m -60.66 -28.03 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.421 -0.354 . . . . 1.04 111.195 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.82 -50.38 50.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 1.75 110.853 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.418 ' HB3' ' CH2' ' A' ' 176' ' ' TRP . 1.4 m-20 -59.91 -32.9 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.69 110.802 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 169' ' ' LEU . 1.2 mt -63.73 -61.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.47 111.001 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.489 ' N ' HG22 ' A' ' 173' ' ' ILE . . . -49.2 -34.25 14.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.26 111.01 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.585 HD23 ' CD1' ' A' ' 176' ' ' TRP . 0.5 OUTLIER -67.43 -61.61 1.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.92 110.688 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.585 ' CD1' HD23 ' A' ' 175' ' ' LEU . 22.1 m0 -45.66 -51.01 12.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.974 -0.557 . . . . 0.36 110.807 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.6 mtp -53.03 -52.64 57.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 1.5 110.797 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.1 m -50.01 -44.67 51.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.42 110.823 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -53.84 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 2.25 110.859 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -47.38 -38.98 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.77 111.065 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -51.78 -49.82 61.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.82 111.616 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.51 -27.07 24.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.742 0.306 . . . . 1.64 111.704 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -65.89 -73.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.445 0.535 . . . . 2.01 112.445 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -93.86 -38.56 11.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.722 0.638 . . . . 0.43 112.722 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 185' ' ' LEU . 5.4 mt -64.91 -36.53 84.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.153 0.427 . . . . 0.56 112.153 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -48.09 -56.96 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.735 0.302 . . . . 1.59 111.313 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.6 m -48.25 -55.61 10.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.375 . . . . 1.16 111.249 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.449 ' CZ2' ' ND2' ' A' ' 192' ' ' ASN . 44.0 t90 -63.63 -40.26 96.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.83 111.628 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.3 mt -46.72 -58.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.466 -0.334 . . . . 0.6 111.323 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.41 -29.64 69.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.386 . . . . 2.42 111.089 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.63 -45.64 85.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 1.96 111.184 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.449 ' ND2' ' CZ2' ' A' ' 188' ' ' TRP . 1.7 t-20 -73.27 -17.59 61.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 1.86 111.771 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.94 4.69 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.323 -0.941 . . . . 1.14 113.537 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.68 178.02 45.51 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.539 -0.839 . . . . 0.37 113.095 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TRP . . . . . 0.89 ' CZ2' HD13 ' A' ' 14' ' ' ILE . 50.7 m95 -47.48 -45.47 26.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.729 0.3 . . . . 0.47 110.505 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -48.72 -32.76 8.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.252 -0.431 . . . . 2.16 110.419 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . 0.742 ' O ' HD12 ' A' ' 201' ' ' LEU . . . -73.75 -39.5 64.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.32 110.094 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.826 ' CE2' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -63.11 -62.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 1.28 110.278 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 195' ' ' TRP . 0.2 OUTLIER -46.53 -49.97 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.758 -0.655 . . . . 0.87 111.605 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.72 -37.34 87.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 2.23 111.349 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.747 HD13 ' CD1' ' A' ' 144' ' ' TRP . 0.1 OUTLIER -63.25 -58.35 7.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.303 0.483 . . . . 0.93 112.303 -179.076 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.516 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 12.0 m-85 -100.37 9.69 42.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.65 0.611 . . . . 1.05 112.65 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -78.23 149.18 33.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.324 -0.941 . . . . 0.89 112.633 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 -158.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.612 2.208 . . . . 2.11 112.24 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.3 m -118.26 79.1 1.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 3.57 110.864 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' MET . . . . . . . . . . . . . 1.9 mtm 69.21 54.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 6.74 110.889 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.26 -0.876 . . . . 7.51 110.943 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.845 0.355 . . . . 9.5800000000000001 111.171 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.43 -78.91 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 5.8700000000000001 111.102 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.65 -154.18 1.93 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 4.3600000000000003 112.419 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -179.88 126.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.8 0.334 . . . . 7.6399999999999997 110.923 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 7' ' ' THR . 8.8 t -177.52 58.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 3.0699999999999998 110.898 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.51 154.01 1.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.758 . . . . 2.2999999999999998 112.42 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.456 ' CG ' ' CD1' ' A' ' 195' ' ' TRP . 4.5 m-85 -112.63 22.52 14.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.55 0.214 . . . . 1.74 111.467 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 63.13 62.91 0.96 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.85 0.357 . . . . 2.2000000000000002 110.833 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -49.48 -41.12 39.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 2.3900000000000001 110.923 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 22.1 ttp85 -70.38 -32.15 69.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 2.27 110.838 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -79.51 -30.09 41.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 2.1200000000000001 110.894 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.89 HD13 ' CZ2' ' A' ' 195' ' ' TRP . 5.8 mt -67.32 -44.83 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.256 -0.429 . . . . 0.75 111.154 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.703 HG23 HD12 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -71.44 -44.66 71.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.34000000000000002 111.06 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.2 -39.18 92.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.84999999999999998 110.87 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -60.67 -48.0 83.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 2.0600000000000001 110.838 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 151' ' ' PHE . 66.1 t80 -54.95 -52.87 61.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 0.88 110.91 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 11.0 mt -63.17 -38.75 82.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.69999999999999996 111.111 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -56.87 -37.81 71.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.279 -0.419 . . . . 1.8100000000000001 110.808 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -79.11 -55.49 5.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 1.23 110.827 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -51.93 -31.02 26.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 1.9399999999999999 110.869 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.499 HD11 ' HD2' ' A' ' 28' ' ' TYR . 11.5 tp -84.08 -40.81 17.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 1.23 110.747 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -49.18 -27.14 3.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 1.3 111.139 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -29.72 10.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.387 -0.37 . . . . 2.7599999999999998 110.75 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.424 ' CD ' HG22 ' A' ' 159' ' ' VAL . 14.2 mtt85 -93.05 -35.68 13.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.368 -0.378 . . . . 3.4900000000000002 111.055 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.95 -24.77 15.74 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.679 -0.772 . . . . 1.8600000000000001 112.849 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.78 ' CD2' HG21 ' A' ' 162' ' ' VAL . 0.8 OUTLIER -47.21 106.11 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.877 0.37 . . . . 1.1699999999999999 110.959 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -64.87 110.71 2.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.101 -0.5 . . . . 2.4500000000000002 110.856 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.441 ' CZ2' ' HA ' ' A' ' 32' ' ' ALA . 21.5 t90 -96.38 -66.27 0.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 1.1699999999999999 111.177 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.543 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.4 OUTLIER 72.6 24.51 2.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 2.3799999999999999 111.24 -179.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 31' ' ' ASP . . . 75.77 -58.7 0.54 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.555 -0.293 . . . . 1.28 111.598 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.61 68.75 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.638 -0.792 . . . . 1.8700000000000001 112.597 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 48.02 30.97 2.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.331 . . . . 3.9100000000000001 110.958 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.51 ' C ' HG12 ' A' ' 36' ' ' VAL . 3.7 t70 -106.14 31.69 4.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 4.4699999999999998 110.906 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG12 ' C ' ' A' ' 35' ' ' ASP . 0.2 OUTLIER 178.95 107.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 4.8499999999999996 111.117 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.36 -57.94 9.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.436 . . . . 6.7300000000000004 110.875 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -143.32 179.68 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 8.2200000000000006 110.912 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.3 51.29 2.0 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 6.7000000000000002 110.859 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.32 -28.75 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 9.6300000000000008 111.126 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -47.76 -39.92 19.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.356 -0.383 . . . . 6.21 110.977 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -56.56 127.17 29.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 7.4299999999999997 110.784 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . . . -98.2 141.05 22.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 4.54 111.085 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 43' ' ' ALA . 37.2 Cg_exo -59.75 82.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.422 2.081 . . . . 5.7800000000000002 112.288 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -165.98 177.63 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 6.6799999999999997 111.017 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.26 -68.56 0.42 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.818 -0.705 . . . . 3.4100000000000001 112.442 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.2 p 53.96 30.66 12.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 3.8700000000000001 110.993 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.41 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 4.6 pt-20 -129.82 4.47 4.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.28 -0.418 . . . . 3.3300000000000001 111.851 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.591 ' HA ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -147.25 38.1 0.95 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.842 0.353 . . . . 1.52 110.781 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -100.22 -25.72 14.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 2.8399999999999999 111.28 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.569 ' HB ' HG23 ' A' ' 199' ' ' VAL . 0.0 OUTLIER -114.81 -24.17 3.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.504 -0.316 . . . . 0.94999999999999996 111.672 -179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 49' ' ' SER . 11.0 p -62.78 -41.07 91.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.97 0.414 . . . . 0.67000000000000004 110.626 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.482 ' CD2' HG13 ' A' ' 93' ' ' VAL . 66.7 m-70 -74.03 -53.96 8.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.991 -0.549 . . . . 1.0900000000000001 110.584 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.6 mt -48.34 -44.27 34.13 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.04 -0.527 . . . . 2.0499999999999998 110.611 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 202' ' ' TYR . . . -68.58 -60.92 2.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.987 -0.551 . . . . 0.60999999999999999 110.847 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.826 HD12 ' CE2' ' A' ' 198' ' ' PHE . 9.0 tt -46.45 -42.77 15.86 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.021 -0.536 . . . . 1.1000000000000001 110.998 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -30.13 68.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 2.8300000000000001 110.91 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -77.91 -50.56 11.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 1.72 110.77 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.509 ' HB3' HG21 ' A' ' 148' ' ' VAL . . . -48.13 -41.15 25.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.5 111.15 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.422 ' HA2' HG13 ' A' ' 148' ' ' VAL . . . -53.59 -49.14 58.73 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.55000000000000004 112.522 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -71.51 -46.84 58.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.865 0.364 . . . . 2.0600000000000001 110.864 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.81 -30.29 68.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 1.8799999999999999 111.115 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -92.34 -59.26 2.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.348 -0.387 . . . . 1.48 111.073 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 38.6 t -47.29 -36.36 9.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 1.0700000000000001 110.988 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -75.87 -29.05 58.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 3.0800000000000001 110.989 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -59.7 -46.93 87.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.369 . . . . 3.04 110.821 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -78.95 -70.05 0.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 1.3500000000000001 110.855 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 65.56 13.78 9.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 2.98 111.748 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.63 -43.69 1.42 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 120.517 -0.849 . . . . 1.05 112.454 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.07 -170.49 1.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.657 0.265 . . . . 2.2599999999999998 110.826 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.768 ' CZ ' ' HB1' ' A' ' 149' ' ' ALA . 5.0 m-85 68.54 -84.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.113 -0.494 . . . . 1.5700000000000001 111.774 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.04 -68.84 0.16 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.783 0.325 . . . . 0.92000000000000004 111.28 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.31 -30.18 69.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.337 -0.392 . . . . 3.21 110.715 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 57.0 ttp -56.98 -22.21 36.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 1.45 111.16 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.63 -12.56 47.09 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.038 0.384 . . . . 2.1400000000000001 112.038 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.6 t -66.6 -30.7 71.05 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.74 0.305 . . . . 1.6399999999999999 110.715 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.02 -61.12 2.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 2.52 110.757 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 129' ' ' ARG . 8.8 tt -50.37 147.36 4.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.462 . . . . 1.8400000000000001 110.812 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.654 ' HB3' HG21 ' A' ' 125' ' ' THR . 11.5 t-160 -67.38 -123.1 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 116.244 -0.434 . . . . 2.6800000000000002 110.424 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.631 ' O ' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER 179.06 98.07 0.02 OUTLIER 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.659 0.663 . . . . 1.9299999999999999 110.475 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 169' ' ' LEU . 0.2 OUTLIER 167.37 164.5 0.13 Allowed Pre-proline 0 N--CA 1.464 0.237 0 CA-C-N 116.188 -0.46 . . . . 2.79 110.497 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HA ' HD21 ' A' ' 169' ' ' LEU . 39.1 Cg_endo -66.81 -25.52 45.74 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.518 2.145 . . . . 2.1899999999999999 112.07 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.402 ' O ' ' CD2' ' A' ' 124' ' ' PHE . 70.0 t80 -95.17 21.83 7.41 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.248 -0.433 . . . . 3.98 111.317 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.654 HG21 ' HB3' ' A' ' 120' ' ' HIS . 0.6 OUTLIER -128.17 -56.22 1.26 Allowed 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.637 0.256 . . . . 2.2599999999999998 111.075 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.422 ' HA ' HD11 ' A' ' 119' ' ' LEU . . . -45.25 -39.25 6.24 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 1.77 111.612 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.51 -69.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.342 -0.39 . . . . 2.27 111.179 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -60.18 -59.14 10.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.65000000000000002 112.789 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.686 ' HB3' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -47.16 -42.76 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 2.6499999999999999 111.234 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -48.52 -44.88 36.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.354 -0.384 . . . . 1.4399999999999999 110.948 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.22 97.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.57999999999999996 111.162 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 m -64.08 -58.71 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.72999999999999998 111.069 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 57.4 t -48.01 -54.31 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.46999999999999997 111.317 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 47.7 t -61.96 -41.31 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.48999999999999999 111.389 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -50.87 -45.0 59.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.306 -0.406 . . . . 2.1400000000000001 110.835 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.67 -34.05 66.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 2.5600000000000001 111.321 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 8.9 mt -50.89 -55.07 18.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.429 -0.351 . . . . 1.0800000000000001 110.807 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.862 ' CD1' HG13 ' A' ' 142' ' ' VAL . 45.9 m-85 -103.56 7.76 37.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 1.3600000000000001 112.047 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 20.6 ttt180 -44.29 -39.51 4.58 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.658 0.266 . . . . 4.3600000000000003 111.392 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.95 76.38 1.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.459 -0.337 . . . . 3.2000000000000002 110.909 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 62.79 147.14 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.736 -0.745 . . . . 0.90000000000000002 112.475 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.862 HG13 ' CD1' ' A' ' 138' ' ' PHE . 2.5 t -99.9 143.01 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.014 0.435 . . . . 1.24 111.445 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.431 ' HA ' ' CZ2' ' A' ' 188' ' ' TRP . 7.7 m-20 -150.65 161.94 41.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.641 . . . . 2.0499999999999998 110.501 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.747 ' CD1' HD13 ' A' ' 201' ' ' LEU . 12.6 m95 -49.96 -62.06 1.78 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.791 0.329 . . . . 0.35999999999999999 110.653 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -48.24 -40.19 21.64 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.746 -0.74 . . . . 0.34000000000000002 112.101 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.89 -36.83 84.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.897 0.379 . . . . 2.2200000000000002 110.316 179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 143' ' ' ASN . 2.4 mt -64.43 -55.56 20.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.106 -0.497 . . . . 0.69999999999999996 110.03 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.609 HG23 ' HZ ' ' A' ' 198' ' ' PHE . 0.9 OUTLIER -48.3 -36.09 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.773 -0.648 . . . . 0.34999999999999998 110.376 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.768 ' HB1' ' CZ ' ' A' ' 112' ' ' PHE . . . -66.5 -39.17 88.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.004 -0.544 . . . . 0.32000000000000001 110.662 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -61.17 -34.22 74.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 1.47 110.829 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 24.5 m-85 -67.7 -61.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 1.28 110.615 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -40.09 18.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.074 -0.512 . . . . 2.25 110.923 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -54.99 40.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 1.1499999999999999 110.772 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -55.71 -34.11 60.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.638 -0.792 . . . . 0.37 112.374 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -66.35 -34.15 87.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.748 -0.739 . . . . 0.39000000000000001 112.328 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.83 -42.87 82.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.58999999999999997 110.999 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 3.5 ttp -64.12 -41.35 97.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.111 -0.495 . . . . 1.1499999999999999 110.841 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.427 ' HA ' HD13 ' A' ' 173' ' ' ILE . 0.0 OUTLIER -60.99 -62.14 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 1.1899999999999999 110.818 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.424 HG22 ' CD ' ' A' ' 26' ' ' ARG . 1.2 t -48.74 -34.33 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.77000000000000002 110.841 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -61.26 -39.76 91.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 2.3300000000000001 110.596 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.09 -62.26 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.1699999999999999 110.774 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.78 HG21 ' CD2' ' A' ' 28' ' ' TYR . 0.5 OUTLIER -53.23 -25.22 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.91000000000000003 111.209 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -72.6 -41.87 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.4 -0.364 . . . . 1.6499999999999999 110.572 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -93.39 23.53 4.46 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.495 . . . . 4.0099999999999998 111.785 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 69.7 32.92 3.12 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.75 0.31 . . . . 2.5699999999999998 111.281 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.75 46.43 2.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 1.0600000000000001 110.87 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -51.14 -53.64 46.51 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 1.4099999999999999 111.217 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 167' ' ' SER . 76.3 Cg_exo -47.83 -28.49 9.92 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.657 2.238 . . . . 0.63 112.699 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 122' ' ' THR . 0.5 OUTLIER -64.93 -30.3 71.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.398 -0.364 . . . . 1.6399999999999999 111.129 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 167' ' ' SER . 2.6 m -60.66 -28.03 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.421 -0.354 . . . . 1.04 111.195 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -68.82 -50.38 50.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.843 0.354 . . . . 1.75 110.853 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.418 ' HB3' ' CH2' ' A' ' 176' ' ' TRP . 1.4 m-20 -59.91 -32.9 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 1.6899999999999999 110.802 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.543 HD12 ' O ' ' A' ' 169' ' ' LEU . 1.2 mt -63.73 -61.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.46999999999999997 111.001 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.489 ' N ' HG22 ' A' ' 173' ' ' ILE . . . -49.2 -34.25 14.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.26000000000000001 111.01 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.585 HD23 ' CD1' ' A' ' 176' ' ' TRP . 0.5 OUTLIER -67.43 -61.61 1.82 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.92000000000000004 110.688 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.585 ' CD1' HD23 ' A' ' 175' ' ' LEU . 22.1 m0 -45.66 -51.01 12.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.974 -0.557 . . . . 0.35999999999999999 110.807 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 91.6 mtp -53.03 -52.64 57.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.046 -0.525 . . . . 1.5 110.797 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 4.1 m -50.01 -44.67 51.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.068 -0.515 . . . . 0.41999999999999998 110.823 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -53.84 -68.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.072 -0.513 . . . . 2.25 110.859 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -47.38 -38.98 14.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.77000000000000002 111.065 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 15' ' ' VAL . 0.5 OUTLIER -51.78 -49.82 61.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.067 -0.515 . . . . 0.81999999999999995 111.616 -179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.51 -27.07 24.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.742 0.306 . . . . 1.6399999999999999 111.704 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.414 ' HB3' ' CD2' ' A' ' 184' ' ' HIS . 3.9 ttt180 -65.89 -73.51 0.13 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.445 0.535 . . . . 2.0099999999999998 112.445 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 183' ' ' ARG . 4.1 m-70 -93.86 -38.56 11.16 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.722 0.638 . . . . 0.42999999999999999 112.722 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.427 ' HA ' HD23 ' A' ' 185' ' ' LEU . 5.4 mt -64.91 -36.53 84.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.153 0.427 . . . . 0.56000000000000005 112.153 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -48.09 -56.96 6.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.735 0.302 . . . . 1.5900000000000001 111.313 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 85.6 m -48.25 -55.61 10.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.376 -0.375 . . . . 1.1599999999999999 111.249 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.449 ' CZ2' ' ND2' ' A' ' 192' ' ' ASN . 44.0 t90 -63.63 -40.26 96.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.4 . . . . 0.82999999999999996 111.628 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.3 mt -46.72 -58.36 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.466 -0.334 . . . . 0.59999999999999998 111.323 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -67.41 -29.64 69.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.386 . . . . 2.4199999999999999 111.089 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.63 -45.64 85.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.349 -0.387 . . . . 1.96 111.184 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.449 ' ND2' ' CZ2' ' A' ' 188' ' ' TRP . 1.7 t-20 -73.27 -17.59 61.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 1.8600000000000001 111.771 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.94 4.69 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.323 -0.941 . . . . 1.1399999999999999 113.537 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 76.68 178.02 45.51 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.539 -0.839 . . . . 0.37 113.095 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TRP . . . . . 0.89 ' CZ2' HD13 ' A' ' 14' ' ' ILE . 50.7 m95 -47.48 -45.47 26.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.729 0.3 . . . . 0.46999999999999997 110.505 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -48.72 -32.76 8.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.252 -0.431 . . . . 2.1600000000000001 110.419 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . 0.742 ' O ' HD12 ' A' ' 201' ' ' LEU . . . -73.75 -39.5 64.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.32000000000000001 110.094 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.826 ' CE2' HD12 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -63.11 -62.12 1.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.79 -0.641 . . . . 1.28 110.278 179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 195' ' ' TRP . 0.2 OUTLIER -46.53 -49.97 5.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.758 -0.655 . . . . 0.87 111.605 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -64.72 -37.34 87.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.838 0.352 . . . . 2.23 111.349 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.747 HD13 ' CD1' ' A' ' 144' ' ' TRP . 0.1 OUTLIER -63.25 -58.35 7.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.303 0.483 . . . . 0.93000000000000005 112.303 -179.076 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.516 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 12.0 m-85 -100.37 9.69 42.3 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.65 0.611 . . . . 1.05 112.65 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -78.23 149.18 33.69 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.324 -0.941 . . . . 0.89000000000000001 112.633 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.86 -158.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.612 2.208 . . . . 2.1099999999999999 112.24 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.3 m -118.26 79.1 1.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 3.5699999999999998 110.864 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' MET . . . . . . . . . . . . . 1.9 mtm 69.21 54.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 6.7400000000000002 110.889 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.26 -0.876 . . . . 7.5099999999999998 110.943 179.965 . . . . . . . . 1 1 . 1 stop_ save_